CorMedix, Inc.
(NASDAQ : CRMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.12%494.611.0%$1073.81m
ABTAbbott Laboratories 1.99%113.050.8%$978.35m
DHRDanaher Corp. -1.00%265.760.7%$820.29m
MDTMedtronic Plc 0.44%125.410.6%$625.55m
ISRGIntuitive Surgical, Inc. -0.17%903.922.3%$455.30m
BDXBecton, Dickinson & Co. 0.13%240.531.0%$384.31m
ALGNAlign Technology, Inc. 3.47%626.856.3%$314.75m
DXCMDexCom, Inc. -1.03%427.267.8%$303.73m
SYKStryker Corp. -0.41%261.571.3%$291.96m
BSXBoston Scientific Corp. 0.17%43.871.0%$277.81m
EWEdwards Lifesciences Corp. -0.57%104.160.4%$239.26m
BAXBaxter International, Inc. 0.41%81.261.8%$238.71m
ZBHZimmer Biomet Holdings, Inc. -0.34%163.911.7%$235.54m
AAgilent Technologies, Inc. -0.27%146.851.6%$235.00m
IDXXIDEXX Laboratories, Inc. -1.53%606.493.8%$212.72m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.